HK1149770A1 - Compositions, methods and kits - Google Patents

Compositions, methods and kits

Info

Publication number
HK1149770A1
HK1149770A1 HK11103550.3A HK11103550A HK1149770A1 HK 1149770 A1 HK1149770 A1 HK 1149770A1 HK 11103550 A HK11103550 A HK 11103550A HK 1149770 A1 HK1149770 A1 HK 1149770A1
Authority
HK
Hong Kong
Prior art keywords
kits
compositions
methods
Prior art date
Application number
HK11103550.3A
Other languages
English (en)
Chinese (zh)
Inventor
Thomas Plocher
Manuel Campos
Richard Harland
Todd Johnson
Trent Harbison
Dan Keil
Original Assignee
Novartis Tiergesundheit Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40757034&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1149770(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Tiergesundheit Ag filed Critical Novartis Tiergesundheit Ag
Publication of HK1149770A1 publication Critical patent/HK1149770A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047Cells of the immune system
    • G01N33/5052Cells of the immune system involving B-cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
HK11103550.3A 2008-03-28 2011-04-07 Compositions, methods and kits HK1149770A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4026008P 2008-03-28 2008-03-28
PCT/EP2009/053281 WO2009118273A1 (en) 2008-03-28 2009-03-20 Compositions, methods and kits

Publications (1)

Publication Number Publication Date
HK1149770A1 true HK1149770A1 (en) 2011-10-14

Family

ID=40757034

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11103550.3A HK1149770A1 (en) 2008-03-28 2011-04-07 Compositions, methods and kits

Country Status (15)

Country Link
US (2) US9046528B2 (xx)
EP (1) EP2262828B1 (xx)
KR (1) KR101647159B1 (xx)
CN (1) CN101981052B (xx)
AR (1) AR071104A1 (xx)
BR (1) BRPI0909493A2 (xx)
CA (1) CA2719041C (xx)
CL (1) CL2009000768A1 (xx)
CO (1) CO6290771A2 (xx)
ES (1) ES2551699T3 (xx)
HK (1) HK1149770A1 (xx)
MX (1) MX2010010614A (xx)
PL (1) PL2262828T3 (xx)
RU (1) RU2555530C2 (xx)
WO (1) WO2009118273A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2262828T3 (pl) 2008-03-28 2016-03-31 Elanco Tiergesundheit Ag Kompozycje, sposoby i zestawy
ES2617232T3 (es) * 2010-04-23 2017-06-15 Intervet International B.V. Una vacuna que comprende células inactivadas de bacterias Haemophilus parasuis de serotipo 5
CN102399724B (zh) * 2011-11-08 2013-01-02 山东省农业科学院畜牧兽医研究所 一种副猪嗜血杆菌lc株及其应用
CN104306964B (zh) * 2014-11-12 2017-10-10 四川农业大学 重组副猪嗜血杆菌免疫保护性抗原HbpA2的用途及用其制备的亚单位疫苗
CN104404056B (zh) * 2014-11-12 2017-07-18 四川农业大学 一种重组副猪嗜血杆菌免疫保护性抗原HbpA2及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713071B1 (en) * 1998-10-22 2004-03-30 Pfizer Inc. Proteins from actinobacillus pleuropneumoniae
US20090087878A9 (en) 1999-05-06 2009-04-02 La Rosa Thomas J Nucleic acid molecules associated with plants
RU2268933C1 (ru) * 2004-04-21 2006-01-27 Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ ВНИИЗЖ) ШТАММ Haemophilus parasuis СК-1 - ВОЗБУДИТЕЛЬ ГЕМОФИЛЕЗНОГО ПОЛИСЕРОЗИТА СВИНЕЙ ДЛЯ ИЗГОТОВЛЕНИЯ ДИАГНОСТИЧЕСКИХ И ВАКЦИННЫХ ПРЕПАРАТОВ
US20090131524A1 (en) * 2005-06-07 2009-05-21 Buck Institute Sialic acid abc transporters in prokaryotes therapeutic targets
PL2262828T3 (pl) 2008-03-28 2016-03-31 Elanco Tiergesundheit Ag Kompozycje, sposoby i zestawy
EP2496254A2 (en) * 2009-11-04 2012-09-12 Regents Of The University Of Minnesota Haemophilus parasuis polypeptides and methods of use

Also Published As

Publication number Publication date
CO6290771A2 (es) 2011-06-20
EP2262828A1 (en) 2010-12-22
US20110014225A1 (en) 2011-01-20
CA2719041A1 (en) 2009-10-01
AR071104A1 (es) 2010-05-26
CL2009000768A1 (es) 2011-07-01
ES2551699T3 (es) 2015-11-23
KR101647159B1 (ko) 2016-08-09
BRPI0909493A2 (pt) 2017-11-07
US20150293118A1 (en) 2015-10-15
PL2262828T3 (pl) 2016-03-31
MX2010010614A (es) 2010-11-09
US10261092B2 (en) 2019-04-16
CN101981052B (zh) 2014-11-26
RU2555530C2 (ru) 2015-07-10
EP2262828B1 (en) 2015-09-30
RU2010143903A (ru) 2012-05-10
KR20100139096A (ko) 2010-12-31
WO2009118273A1 (en) 2009-10-01
US9046528B2 (en) 2015-06-02
CN101981052A (zh) 2011-02-23
CA2719041C (en) 2016-08-16

Similar Documents

Publication Publication Date Title
IL210153A0 (en) Nutrigenomics methods and compositions
ZA201203603B (en) Lyophilization methods, compositions, and kits
IL212822A0 (en) Anti-cxcr1 compositions and methods
GB0819530D0 (en) Methods and compositions
IL210559A0 (en) Novel compositions and methods
GB0706077D0 (en) Methods, Compositions and uses thereof
IL210588A0 (en) Novel compositions and methods
GB0817585D0 (en) Novel compositions and methods
EP2285953A4 (en) RNA POLYPHOSPHATASE COMPOSITIONS, KITS AND THEIR USE
HK1149770A1 (en) Compositions, methods and kits
HRP20150021T1 (xx) Spojevi fenantrenona, pripravci i postupci
GB0811250D0 (en) Methods and compositions
AU2008905036A0 (en) Compositions, kits and methods
AU2014200650C1 (en) Anti-CXCR1 compositions and methods
GB0804427D0 (en) Methods and kits
GB0818399D0 (en) Methods and compositions
GB0816534D0 (en) Compositions and methods
GB0811152D0 (en) Methods and compositions
GB0803464D0 (en) Methods and compositions
AU2008903953A0 (en) Methods and compositions
AU2008904402A0 (en) Methods and compositions

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190314